Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
批准号:
10689658
负责人:
Thomas Levin Geiser Andersen
金额:
$45.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-05-31
关键词:
AffectAgeAlbers-Schonberg diseaseAntibody TherapyAutomobile DrivingBackBindingBiomechanicsBiopsy SpecimenBone DiseasesBone Formation StimulationBone Marrow TransplantationBone ResorptionBone remodelingBone structureCD14 geneCaringCell NucleusCellsCementationCharacteristicsCoculture TechniquesCommunicationComplementComputer AssistedCouplingDataDevelopmentDiseaseElderlyEndosteal CellFamilyFutureGenesGenetic TranscriptionGoalsHeterozygoteHumanImageIn Situ HybridizationIn VitroInheritedInvestigationKnowledgeMature BoneMediatingMolecularMusMutationOsteoblastsOsteoclastsOsteogenesisOsteoporosisPathologicPatientsPeripheralPhenotypePhysiologicalPhysiologyProcessResourcesSamplingSkeletal boneTNFSF11 geneTestingWithdrawalWorkautosomebonebone fragilitybone lossbone masscell typecollagenase 3costhuman modelin vivoinnovationinsightlensmonocytemouse modelmultimodalitynovelnovel therapeutic interventionnovel therapeuticsoverexpressionprogenitorprogramssexsingle nucleus RNA-sequencingskeletaltherapeutic targettooltranscriptomicstranslational impacttreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
Coupling, or communication between the bone-resorbing osteoclasts and bone-forming osteoblasts
during bone remodeling, is a key step in the bone remodeling cycle. While compelling evidence shows that bone
loss and fragility with age and osteoporosis result from corrupted coupling, the precise mechanism of osteoclast-
osteoblast communication remains unclear. Thus, although stimulating coupling is a theoretically attractive
therapeutic target, current treatments for osteoporosis, a common disorder affecting 54 million of the elderly in
the US alone, are limited to either inhibiting osteoclastic bone resorption or stimulating osteoblastic bone
formation. Our long-term goal is to determine the mechanism of osteoclast-osteoblast communication critical for
coupling of bone formation to resorption during physiological bone remodeling, using rare osteopetrotic diseases
as a tool. Rare bone diseases provide important insights into typical bone physiology and knowledge gained
from these diseases has already led to new therapies for osteoporosis.
In this proposal, we utilize samples from patients with autosomal dominant osteopetrosis type II (ADOII),
a rare inheritable osteopetrosis characterized by high bone mass and skeletal fragility and complement human
studies with mouse models. ADOII results from heterozygous mutations in the CLCN7 gene, which encodes the
ClC-7 Cl-/H+ exchanger essential for osteoclastic bone-resorption. While the lack of osteoclastic resorption
clearly contributes to bone phenotype, bone formation is also inappropriately high. In preliminary data
investigating the bone structural unit (BSU) composition of ADOII bones, we found bone formation is primarily
remodeling based, with excess bone formation called overflow remodeling. Osteoclasts are abundant and
scalloped cement lines suggest an intermittent pit-like resorption mode, which in combination with overflow
remodeling results in a characteristic puzzle-like bone structure. We hypothesize that the anabolically active but
poorly resorptive osteoclasts in ADOII overexpress anabolic coupling factors, inappropriately stimulating bone
formation to overfill the resorbed cavities and leading to disorganized puzzle-like bone and fragility.
We will test this hypothesis by combining in vivo and in vitro studies of ADOII patients and mouse models,
multimodal and multiscale imaging, biomechanics and spatial/single-nuclei transcriptomics. Specifically, we will:
1) test if the high bone mass and fragility in human and mouse ADOII is osteoclast-mediated; and 2)
investigate the mechanism of inappropriately high bone formation in ADOII by single nuclei
transcriptomic analysis of physically adjacent osteoclasts and osteoblasts.
The proposed studies take advantage of the unique resource of extant iliac crest bone biopsy specimens
from 15 ADOII patients from a Danish family carrying the CLCN7 (G215R) mutation and age and sex matched
controls, and two mouse models of ADOII, including the analogous Clcn7G213R/+ mutation. Through the lens of
ADOII, these studies will provide unique insights into osteoclast-osteoblast communication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
How bisphosphonates affect bone matrix and remodeling: implications for atypical femoral fractures
-
批准号:10586949
-
项目类别:
-
资助金额:$46.49万
-
财政年份:2023
-
负责人:Thomas Levin Geiser Andersen
-
依托单位:
Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and back
-
批准号:10366576
-
项目类别:
-
资助金额:$49.48万
-
财政年份:2022
-
负责人:Thomas Levin Geiser Andersen
-
依托单位:
Role of senescence in multiple myeloma tumorigenesis
-
批准号:10571047
-
项目类别:
-
资助金额:$40.3万
-
财政年份:2021
-
负责人:Thomas Levin Geiser Andersen
-
依托单位:
Role of senescence in multiple myeloma tumorigenesis
-
批准号:10659259
-
项目类别:
-
资助金额:$39.87万
-
财政年份:2021
-
负责人:Thomas Levin Geiser Andersen
-
依托单位:
Role of senescence in multiple myeloma tumorigenesis
-
批准号:10352638
-
项目类别:
-
资助金额:$39.12万
-
财政年份:2021
-
负责人:Thomas Levin Geiser Andersen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: